Revelation Biosciences
Stock Forecast, Prediction & Price Target
Revelation Biosciences Financial Estimates
Revelation Biosciences Revenue Estimates
Revelation Biosciences EBITDA Estimates
Revelation Biosciences Earnings per Share Estimates
| Passed | Analyst forecast | ||||||
|---|---|---|---|---|---|---|---|
| Metric | 12/31/2021 | 12/31/2022 | 12/31/2023 | 12/31/2025 | 12/31/2026 | 12/31/2027 | 12/31/2028 |
Revenue
% change YoY
| $0 N/A | $0 0% | $0 0% | Avg: $0 Low: $0 High: $0 avg. 0% | Avg: $48.97M Low: $48.97M High: $48.97M avg. 0% | Avg: $2.28M Low: $2.28M High: $2.28M avg. -95.33% | Avg: $34.69M Low: $34.69M High: $34.69M avg. 1418.87% |
Net Income
% change YoY
| $-11.98M N/A | $-10.79M 9.94% | $-120.25K 98.88% | Avg: $-1.19M Low: $-1.59M High: $-792.63K avg. -895.34% | Avg: $-818.53K Low: $-818.53K High: $-818.53K avg. 31.61% | Avg: $-722.50K Low: $-722.50K High: $-722.50K avg. 11.73% | Avg: $1.05M Low: $1.05M High: $1.05M avg. 246.20% |
EBITDA
% change YoY
| $-11.93M N/A | $-10.83M 9.16% | $-95.20K 99.12% | Avg: $0 Low: $0 High: $0 avg. 100% | Avg: $0 Low: $0 High: $0 avg. 0% | Avg: $0 Low: $0 High: $0 avg. 0% | Avg: $0 Low: $0 High: $0 avg. 0% |
EPS
% change YoY
| -$1,275.02 N/A | -$600.77 52.88% | -$0.53 99.91% | Avg: -$5.24 Low: -$6.99 High: -$3.47 avg. -887.73% | Avg: -$3.58 Low: -$3.58 High: -$3.58 avg. 31.61% | Avg: -$3.16 Low: -$3.16 High: -$3.16 avg. 11.73% | Avg: $4.62 Low: $4.62 High: $4.62 avg. 246.20% |
Operating Expenses
% change YoY
| $11.95M N/A | $10.86M -9.08% | $8.65M -20.32% | Avg: $0 Low: $0 High: $0 avg. -100% | Avg: $0 Low: $0 High: $0 avg. 0% | Avg: $0 Low: $0 High: $0 avg. 0% | Avg: $0 Low: $0 High: $0 avg. 0% |
FAQ
What is Revelation Biosciences stock earnings growth forecast?
Wall Street analysts estimate the annual average earnings growth rate of -151.44% in 2025-2028.
We have gathered data from 2 analysts. Their low estimate is -1.59M, average is -1.19M and high is -792.63K.
What is Revelation Biosciences stock revenue growth forecast?
Wall Street analysts forecast annual average revenue growth of 330.88% in 2025-2028.
We have gathered data from 2 analysts. Their low revenue estimate is N/A, average is N/A and high is N/A.
What is Revelation Biosciences stock earnings per share growth forecast?
Wall Street analysts forecast annual average earnings growth of -149.54% in 2025-2028.
We have gathered data from 2 analysts. Their low earnings per share estimate is -$6.99, average is -$5.24 and high is $-3.46.